EST
RMD icon

EA Series Trust’s ResMed RMD Stock Holding History

EA Series Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$215K Buy
+984
New +$219K 0.01% 1060

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EA Series Trust's RMD Position: Q2 2023 in Review

EA Series Trust opened a new position in ResMed (RMD) in Q2 2023: 984 shares worth $215K. The stake represents 0.01% of the portfolio and ranks #1060 among its holdings.

731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

  • EA Series Trust held 984 shares of ResMed worth $215K as of Q2 2023.
  • ResMed was a new EA Series Trust position in Q2 2023.
  • ResMed made up 0.01% of EA Series Trust's portfolio in Q2 2023, its #1060 holding.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.